期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心力衰竭的分子生物学研究进展 被引量：3

The Progress of Study about Molecular Biology in Heart Failure
下载PDF
导出
摘要 慢性心力衰竭患者相关基因表达水平的变化,提示心力衰竭患者相关基因表达异常是重要的分子生物学机制,并可作为判断充血性心力衰竭(CHF)严重程度的指标。 This article reviews the changes about related gcne expression level in patients with heart failure, indicating that abnormal expression of related gene in patients with CHF is not only its most important molecular biological mechanism,but also can serve as markers to judge the severity and the prognosis of CHF.
作者 董榆
机构地区 大理学院附属医院
出处 《医学综述》 2006年第7期399-401,共3页 Medical Recapitulate
关键词 心力衰竭 分子生物学 缺血 缺氧 Heart failure Molecular biology lschemia Hypoxia
分类号 R541.613 [医药卫生—心血管疾病]
  • 相关文献

参考文献13

二级参考文献112

  • 1[1]Tyagi S C. Extracellular matrix dynamics in heart fai-lure: a prospect for gene therapy. J Cell Biochem, 1998,68:403-410.
  • 2[2]Klappacher G, Franzen P, Haab D, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol, 1995, 75:913-978.
  • 3[3]Diezd J, Lavides C, Mayor G. Increase serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation, 1995, 91:1450-1456.
  • 4[4]Frohlich E D. Fibrosis and ischemia: the real risks in hypertensive heart disease.Am J Hypertens , 2001 ,14(6 Pt 2):194S-199S.
  • 5[5]Sanderson J E. Diastolic heart failure and the extracellular matrix. Int J Cardiol, 1997,62:19-21.
  • 6[6]Poulsen S H, Host N B, Jensen S E, et al. Relationship between serum amino-terminal propeptide of type Ⅲ procollagen and changes of left ventricular function after acute myocardial infarction. Circulation, 2000 ,101:1527-1532.
  • 7[7]Kim S, Yoshiyama M, Izumi Y, et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation , 2001 ,103:148-154.
  • 8[8]Brilla C G, Rupp H, Funck R, et al. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J, 1995, 16(Suppl 0):107-109.
  • 9[9]Zannad F, Alla F, Dousset B,et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation , 2000 ,102:2700-2706.
  • 10Visse, Robert, et al. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry[J]. Cire Res. 2003, 92: 827-839.

共引文献59

同被引文献14

引证文献3

二级引证文献44

医学综述
2006年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部